Thielen, F. W., Büyükkaramikli, N. C., Riemsma, R., Fayter, D., Armstrong, N., Wei, C., . . . Corro Ramos, I. (2018). Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal. Pharmacoeconomics.
Citación estilo ChicagoThielen, Frederick W., et al. "Obinutuzumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal." Pharmacoeconomics 2018.
Cita MLAThielen, Frederick W., et al. "Obinutuzumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Advanced Follicular Lymphoma: An Evidence Review Group Evaluation of the NICE Single Technology Appraisal." Pharmacoeconomics 2018.